What are the names of the targeted therapy drugs for acute myeloid leukemia?
There are many targeted treatments for acute myeloid leukemia, such as: Veneroclax, midostemine, gittinib, quizartinib, avonib, gemtubizab, idarobin, azacitidine, homoharringtonine, daunorubin, cytarinoside, decitobin, cladribine, mitoxantrone, etc. There were also targeted drugs targeting specific targets such as FLVT3- itd mutation, IDH2 inhibition, etc. In addition, avonib was an allosteric inhibition of IDH1. Read more exciting novels for free
What are some acute myeloid leukemia success stories?
One success story is about a patient who was diagnosed with acute myeloid leukemia at a young age. Through a combination of intense chemotherapy and a bone marrow transplant from a matching donor, the patient fully recovered. After the treatment, regular check - ups showed no signs of the disease returning, and the patient was able to return to a normal life, going back to school and participating in sports.
What drugs are there to suppress acute marrow leukemia?
The drugs used to treat acute marrow leukemia included chemotherapy drugs and targeted drugs. 1. The main drugs for chemotherapy were mitoxantrone, daunorubin, cytarine, aclacinoxin, homoharringtonine, and so on. The most common adverse reactions were digestive tract reactions (such as nausea, vomiting, etc.) and bone marrow suppression (such as leukemia, chemotherapy, etc.). 2. Target drugs: It mainly included gireitini (FLVT3), vineclakra, midostemine (FLVT3), evonib (IDH1), gemtubiza (CD33), ensidipine (IDH), gilitini, sorafenib, etc. Common side effects included skin itching, rash, and digestive tract reactions; There are also Iso-Citrate Dehydrase 1 or 2 (IDH1/2) Inhibition Agents, such as Ivosidenb (IDH1 Inhibition Agent) and Enasidenb (IDH2 Inhibition Agent), which are effective in the treatment of IDH1 and IDH2 Mutated AML. FLVT3 Tyrosin Kinase Inhibition, such as Midostaurin, Quizartniang, etc.; Newer specific FLVT3 Inhibition, such as Lesturtniang, Gliteritniang, and Crenolanib, are also in clinical trials; In addition, B-cell leukemia 2 (BPL- 2) Inhibition, Hedgehog signaling pathway Inhibition, etc. In addition, azacitidine can be used as a maintenance treatment for acute marrow leukemia. The side effects of oral azacitidine include vomiting, low white blood cell count, and infection, but they are usually controllable. It was important to note that the above medications needed to be used under the guidance of a doctor. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the suppressive drugs for acute marrow leukemia?
Inhibition drugs for acute myeloid leukemia (AML) included chemotherapy drugs and targeted drugs. The main types of chemotherapy drugs were mitoxantrone, daunorubin, cytarine, aclacinoxin, homoharringtonine, etc. The most common adverse reactions were digestive tract reactions (such as nausea, vomiting, etc.) and bone marrow suppression (such as leukemia, chemotherapy, etc.). The targeted drugs mainly included gireitini (FLVT3), vineclakra, midostemine (FLVT3), avonib (IDH1), gemtubizab (CD33), ensidipine (IDH), gilitini, sorafenib, etc. The common side effects of targeted drugs included skin itching, rash, and digestive tract reactions. In addition, the targeted drugs approved by the Food and Drug Administration in 2017 - 2018 for the treatment of leukemia include the FMT3 receptor, midostaurin, the IDH2 receptor, enasidenib, and the IDH1 receptor, Ivosidenib. Among them, midostaurin can be used as first-line treatment and enasidenib can be used as salvage treatment. All the above medicines must be used under the guidance of a doctor. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Can you share more about acute myeloid leukemia success stories?
In one case, a patient with acute myeloid leukemia participated in a clinical trial. The trial was for a new targeted therapy. This treatment was designed to attack the cancer cells while sparing the healthy cells as much as possible. The patient had great results from the trial. Their blood counts returned to normal, and they no longer showed any symptoms of the disease. They are now an example of how research and new treatments can bring hope to those with acute myeloid leukemia.
What are the targeted drugs for large B-cell leukemia?
The commonly used targeted drug for large B-cell leukemia was rituxan. It was a large molecular monoclonal-type drug that mainly targeted B-cell leukemia that was positive for CD20. It could be used for first-line treatment of diffuse large B-cell leukemia. There was also odronextamab, which was an anti-CD 3×CD20 bi-specific protein, and mosunetuzan, which also targeted CD3×CD20. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the side effects of general targeted therapy drugs?
The side effects of targeted therapy mainly included the following aspects: 1. Digestive tract reactions: The targeted drug may stimulate the digestive tract, causing nausea, vomiting, diarrhea, abdominal distension, and other symptoms. This is a relatively common side effect. In addition, the combination of targeted drugs and chemotherapy may also cause a digestive reaction. 2. Liver and kidney toxicity: The drug may be digested in the liver or kidneys after blood circulation, which may increase the burden on the liver and kidney. When used in large doses, it may cause liver and kidney incompetence. 3. Fetal toxicity: Some special targeted drugs have fetal toxicity, such as trastuzumi, which easily passes through the placental barrier and may cause fetal abnormality. Pregnant women should avoid using such targeted drugs with strong fetal toxicity. 4. Others: Fever, chills, bone marrow suppression, allergy (very few patients are allergic to the targeted drug components), and other conditions may occur. In patients treated with Herceptin, symptoms and signs of decreased cardiac function may occur. During the period of taking the medicine, there may be adverse reactions such as peeling, pain, inflammation, etc. In addition, a sudden increase in dosage would cause fluctuations in blood concentration, affect the efficacy, accelerate drug resistance, and even cause serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs that can be used in the late stage of leukemia?
The targeted drugs available for advanced leukemia were rituxed injection, trastuziab for injection, cetuxed injection, mesaconic acid, imatini tablets, erlotinib tablets, etc. In addition, targeted drugs such as BTL were also an important breakthrough in the treatment of leukemia in recent years, and they had a good treatment effect on some types of leukemia. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the names of targeted drugs for head and neck cancer?
As for head and neck tumors, because most head and neck tumors occur in the mucus membrane, more than 90% of them are positive for the receptor for the growth factor of the human skin. Target drugs such as cetuxed mainly act on the growth factor of the human skin. Cetuxed combined with chemotherapy can achieve better efficacy in the treatment of head and neck tumors and reduce tumor relapse and migration. In addition, Bevacobin, Duostat, etc. can inhibit tumor neoplasia and thus tumor growth. However, there was no specific mention of targeted drugs for head and neck adenomas. There was only information on targeted drugs for head and neck tumors. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the drugs for acute gastroenteritis?
The following are some drugs that can be used to quickly relieve the symptoms of acute gastroenteritis: - ** Antiemetic **: Metoclopramine, etc., can relieve the vomiting symptoms associated with acute gastroenteritis. - ** Antispasmodic and painkillers **: Atropine, Anisodine (654 - 2), Belladonia tablets, etc., can relieve spasmodic pain in the digestive tract. - ** Protective agent for gastric mucus **: Bismuth-potassium citrate, sucralfate, aluminum magnesite, and bismuth-pectate can protect the gastric mucus and reduce abdominal pain. - ** Acid suppressors **: Including the proton-pump inhibition drugs (such as omeprazol) and H ^receptor antagonist drugs (such as famotdine and cimetidine), which can suppress gastric acid secretion and reduce the stimulation of gastric acid on the digestive tract. - ** Anti-diarrhea medicine **: Smectite powder, loperamin, belladona sulbendirim tablets, etc., can relieve abdominal pain, diarrhea and other uncomfortable symptoms. - ** Probiotic preparations (Probiotic Intestines)**: Triple Bifidus live bacteria preparation, dual live bacteria preparation, live bacteria preparation of B. licheniformis, yeast boulardi, etc., help to regulate the intestinal flora, improve the intestinal environment, and relieve diarrhea symptoms. - ** Antibiotic **: If it is confirmed that it is a bacteria infection and the symptoms are serious, you can choose to treat it with antibiotics such as noroxin, ciproaxin, levofroxaxin, azithromyc, amoxicilin, ceptriaxone, and penicilin according to the results of the drug sensitivity test. However, it is not recommended to use the medicine by yourself. It needs to be used after the doctor's judgment. It was important to note that all drugs needed to be administered under the guidance of a doctor. If there is acute gastroenteritis, you should seek medical treatment as soon as possible. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for immunity drugs?
The immune drugs mainly included nivulumab injection, pabolizuab injection, atilibizab, duvalliumab, carrelizub, etc. The targeted drugs mainly included trastubiza for injection, pertubiza injection, osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, etc.(There were also many targeted drugs for different cancer types, such as osimertinib and dacotinib targeted for the first-line treatment of lung cancer and lung cancer, alectinib, crizotinib, etc. for the first-line treatment of ALK mutation). <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>